Forbes Middle East recognized trailblazers in the healthcare sector for their outstanding contributions to advancing innovation and sustainable growth ...

Scottish patients placed at the heart of a multi-million pound study of weight-loss medicines. Scottish patients placed at the heart of a ...

Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and a ...

The lawsuit says Novo Nordisk’s offer for drug startup Metsera isn’t reasonably likely to be completed.

Novo Nordisk has notified employees impacted by the drugmaker's job cuts in the vast majority of its locations although the ...

Novo Nordisk cuts over 800 jobs in Plainsboro, part of a global restructuring under the new CEO, reflecting a troubling trend ...

Novo Nordisk, a leader in weight-loss drugs, is offering $6 billion up front with the potential for later milestone payments ...

Pfizer Inc. (NYSE: PFE) is aware of the reckless and unprecedented proposal by Novo Nordisk A/S (NYSE: NVO) to acquire Metsera, Inc. (NASDAQ: MTSR ...

For most employees, there’s a way to check if their company is planning a layoff months before one takes place.

Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited ...

Novo Nordisk has topped Pfizer’s offer for Metsera with a bid of up to US$9 billion, seeking to secure Metsera’s obesity-drug ...

Pfizer Inc. is aware of the reckless and unprecedented proposal by Novo Nordisk A/S to acquire Metsera, Inc. . It is an attempt by a company with a dominant market position to suppress competition in ...